Nvidia BioNeMo enables generative AI for drug discovery
Credit: Gorodenkoff/Shutterstock
Pharma companies can access the Nvidia Clara healthcare suite, including BioNeMo via Amazon SageMaker and AWS ParallelCluster
Welcome to Scientific Computing World
Already registered? Sign in to continue reading
Not got an account? Register for free to continue reading
